Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Carbohydr Polym ; 261: 117847, 2021 Jun 01.
Artigo em Inglês | MEDLINE | ID: mdl-33766343

RESUMO

Surface functionalization of mesoporous silica nanoparticles (MSNs) has been proposed as an efficient strategy for enhancing the biocompatibility and efficiency of an MSN-based carrier platform. Herein, natural polyelectrolyte multilayers composed of poly-l-ornithine (PLO) and carboxymethyl lentinan (LC) were coated on the surface of MSNs through a layer-by-layer (LbL) self-assembly technique, and were characterized by ζ-potential, FTIR, 13C NMR, SEM, TEM, XRD, and TG. The prepared carrier presented alternating positive and negative potentials when coated with the polyelectrolytes, and the surface of MSN-PLO/LC was rougher compared to the naked MSNs. The biocompatibility tests, including cytocompatibility, hemocompatibility, and histocompatibility, showed that MSNs biocompatibility could be improved by modifying LC. A high loading and sustained release drug delivery system was constructed after loading doxorubicin (DOX) into the prepared MSN-PLO/LC, which exhibited significant anti-proliferative efficiency in human cervical cancer cell lines (Hela). Therefore, the PLO/LC LbL NPs (layer-by-layer self-assembled nanoparticles coated with PLO/LC layers) based on MSNs, which is easily prepared by electrostatic interactions, can be considered a promising drug chemotherapeutic platform and delivery technique for future human cervical cancer therapy.


Assuntos
Antineoplásicos/administração & dosagem , Portadores de Fármacos , Lentinano , Animais , Antineoplásicos/farmacocinética , Células Cultivadas , Portadores de Fármacos/síntese química , Portadores de Fármacos/química , Portadores de Fármacos/uso terapêutico , Composição de Medicamentos , Sistemas de Liberação de Medicamentos , Liberação Controlada de Fármacos , Feminino , Células HeLa , Humanos , Lentinano/análogos & derivados , Lentinano/síntese química , Lentinano/química , Lentinano/uso terapêutico , Masculino , Teste de Materiais , Camundongos , Nanopartículas/química , Nanopartículas/uso terapêutico , Polimerização , Polímeros/síntese química , Polímeros/química , Polímeros/uso terapêutico , Porosidade , Coelhos , Dióxido de Silício/química , Ensaios Antitumorais Modelo de Xenoenxerto
2.
Biosens Bioelectron ; 68: 72-77, 2015 Jun 15.
Artigo em Inglês | MEDLINE | ID: mdl-25562733

RESUMO

Co-reactant electrochemiluminescence (ECL) is a simple and effective method for sensitive detection with amplified ECL signals. However, the intermolecular interaction between the luminescent reagents and their corresponding co-reactants, which is widely applied, has disadvantages in poor stability, low efficiency of electron transfer and relatively high loss of energy. In this work, an intramolecular self-enhanced ECL is proposed to settle this problem. Firstly, palladium nanowires (PdNWs) are synthesized with a green procedure in which Lentinan (LNT), one of ß-glucans with a triple helical conformation (t-LNT) in aqueous solution and single chains (s-LNT) at a temperature higher than 130°C, is used as stabilizer and reducing agent. The abtined PdNWs are applied to immobilize polyamidoamine (PAMAM) dendrimer which further reacts with tris (4, 4'-dicarboxylicacid-2, 2'-bipyridyl) ruthenium (II) dichloride to form a new electrochemiluminescent derivative (PdNWs-PAMAM-Ru). In this way, the Ru (II) luminophore and its co-reactive groups (amine groups in PAMAM) exist in the same complex, by which the electronic transmission distance is shortened and the luminous properties including stability and efficiency are enhanced. Moreover, due to the high specific surface areas and good electro-catalytic ability of PdNWs, the obtained PdNWs-PAMAM-Ru can be also applied to immobilize detection antibody (Ab2). Then, a sandwiched and sensitive ECL immunosensor is fabricated for the detection of carcinoembryonic antigen (CEA) with a wide linear ranged from 0.001 ng mL(-1) to 80 ng mL(-1) and a low detection limit of 0.3 pg mL(-1).


Assuntos
Técnicas Biossensoriais , Antígeno Carcinoembrionário/isolamento & purificação , Nanofios/química , Antígeno Carcinoembrionário/química , Dendrímeros/química , Ouro/química , Humanos , Lentinano/síntese química , Lentinano/química , Limite de Detecção , Nanopartículas Metálicas/química , Paládio/química , Rutênio/química , beta-Glucanas/química
3.
Bioorg Med Chem ; 11(10): 2193-203, 2003 May 15.
Artigo em Inglês | MEDLINE | ID: mdl-12713829

RESUMO

A beta-(1-->6)-branched beta-(1-->3)-glucohexaose, present in many biologically active polysaccharides from traditionally herbal medicines such as Ganoderma lucidum, Schizophyllum commune and Lentinus edodes, was synthesized as its lauryl glycoside 32, and its analogues 18, 20 and 33 containing an alpha-(1-->3) linked bond were synthesized. It is interesting to find that coupling of a 3,6-branched acylated trisaccharide trichloroacetimidate donor 9 with 3,6-branched acceptors 13 and 16 with 3'-OH gave the alpha-(1--> 3)-linked hexasaccharides 17 and 19, respectively, in spite of the presence of C-2 ester capable of neighboring group participation. However, coupling of 9 with 4-methoxyphenyl 4,6-O-benzylidene-beta-D-glucopyranoside (27) selectively gave beta-(1-->3)-linked tetrasaccharide 28. Simple chemical transformation of the tetrasaccharide 28 gave acylated tetrasaccharide trichloroacetimidate 29. Coupling of 29 with lauryl (1-->6)-linked disaccharide 26 with 3-OH gave beta-(1-->3)-linked hexasaccharide 30 as the major product. Bioassay showed that in combination with the chemotherapeutic agent cyclophospamide (CPA), the hexaose 18 at a dose of 0.5-1mg/kg substantially increased the inhibition of S(180) for CPA, but decreased the toxicity caused by CPA. Some of these oligosaccharides also inhibited U(14) noumenal tumor in mice effectively.


Assuntos
Antineoplásicos/síntese química , Lentinano/análogos & derivados , Oligossacarídeos/síntese química , Compostos Alílicos/química , Animais , Antineoplásicos/farmacologia , Antineoplásicos/uso terapêutico , Sequência de Carboidratos , Carcinoma de Ehrlich/tratamento farmacológico , Linhagem Celular Tumoral , Ciclofosfamida/farmacologia , Ciclofosfamida/uso terapêutico , Glicosídeos/química , Lentinano/síntese química , Lentinano/uso terapêutico , Masculino , Camundongos , Conformação Molecular , Dados de Sequência Molecular , Estereoisomerismo , Relação Estrutura-Atividade
4.
Jpn J Cancer Res ; 80(2): 95-8, 1989 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-2498253

RESUMO

Anti-HIV effects of lentinan sulfate were investigated by using an HTLV-I-carrying cell line, MT-4, in vitro. Lentinan, a fungal branched (1----3)-beta-D-glucan, was sulfated to various degrees by means of two kinds of procedures using piperidine N-sulfonic acid in dimethyl sulfoxide or chlorosulfonic acid in pyridine. Lentinan sulfate with a sulfur content of more than 13.9% effectively prevented HIV-induced cytopathic effects (CPE) at concentrations of more than 3.3 micrograms/ml. However, low-substituted lentinan sulfate did not prevent HIV-induced CPE at any concentration tested. When the countercation was 50% Na+ and 50% pyridinium ion, the inhibitory capacity was low. Anticoagulant activity of the lentinan sulfate was also assessed.


Assuntos
Antivirais/síntese química , HIV/efeitos dos fármacos , Lentinano/síntese química , Polissacarídeos/síntese química , Anticoagulantes , Antivirais/farmacologia , Divisão Celular/efeitos dos fármacos , Linhagem Celular , Efeito Citopatogênico Viral/efeitos dos fármacos , Imunofluorescência , Antígenos HIV/biossíntese , Vírus Linfotrópico T Tipo 1 Humano , Humanos , Lentinano/análogos & derivados , Lentinano/farmacologia , Lentinano/uso terapêutico , Enxofre/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA